#Antares Vision #Brescia #MCA #Gambia

Antares Vision Group Partners with The Gambia

Antares Vision Group, a leading Italian multinational known for its Track & Trace systems and quality control solutions, has officially entered a strategic partnership with The Medicines Control Agency (MCA) of The Gambia. This collaboration aims to lay the groundwork for a more secure and transparent pharmaceutical landscape through the innovative DIAMIND Government Solutions.

The signing of this agreement represents a significant milestone, not only for Antares Vision Group but also for the healthcare sector in The Gambia. Scheduled to commence in the final quarter of 2025, the project seeks to enhance the safety and transparency of the pharmaceutical supply chain and establish integrated digital systems throughout MCA processes.

In a joint effort, the Antares Vision Group will work closely with local Gambian organization, Africa Agenda Network (AAN). This partnership underlines the commitment to ensure that the local context, needs, and stakeholder perspectives are thoroughly considered. AAN President, Mr. Saul Frazer, emphasized the importance of local collaborations for achieving sustainable success in The Gambia and the broader Economic Community of West African States (ECOWAS) region.

Transformative Impact on the Gambia’s Pharmaceutical Sector

The collaboration is anticipated to yield benefits across several operational dimensions of the MCA. Key aspects of the initiative include:

• - Enhanced Safety and Transparency: Utilizing cutting-edge technology and data analytics to introduce secure regulatory practices.
• - Real-time Monitoring: Providing MCA with tools to track medication registration, distribution, and availability in real-time.
• - Customs Integration: Strengthening oversight on imports and inspections through a seamless customs integration.
• - Improved Regulatory Efficiency: Creating digital platforms that bolster patient safety through efficient regulatory processes.

Gianluca Mazzantini, CEO of Antares Vision Group, expressed enthusiasm about the collaboration stating, “Our solutions are aimed at ensuring secure and efficient pharmaceutical operations, directly benefiting patients and healthcare stakeholders alike.” He acknowledged the invaluable support received from the MCA and particularly credited Mr. Essa Marenah for his leadership during the negotiations.

Roadmap for Future Growth

The project is structured to unfold over several phases within a seven-year framework, aiming to:

• - Broaden Healthcare Digitalization: Implement digital healthcare-related services within the Gambia, ensuring a comprehensive approach to healthcare transformation.
• - Widen Regulatory Scope: Expand oversight to include medical devices, further enhancing patient safety within the healthcare market.
• - Align with National Goals: Ensure that efforts closely align with The Gambia’s National Development Agenda for transformative healthcare.

Under the guidance of AAN Managing Director, Ms. Muna Jallow, the project illustrates a commitment to long-term change, addressing the unique challenges and opportunities faced by The Gambia’s healthcare sector.

In summary, by leveraging its Track & Trace expertise and integrating local engagement, the Antares Vision Group and the MCA are poised to create a robust foundation for the future of healthcare regulation and integrity in The Gambia. This collaboration not only augments the operational capacity of the MCA but also establishes a model for similar initiatives throughout the ECOWAS region, promising better health outcomes and supply chain reliability for all stakeholders involved.